Home › Trials › NCT02526095

Evaluating outcomes of esophageal cancer surgery

National Oesophageal and Gastric Carcinomas Data Base Construction: the FREGAT (French EsoGastric Tumours) Data Base

Observational University Hospital, Lille · NCT02526095

This study looks at how well surgery works for people with esophageal or stomach cancer, including those who had treatment before, by collecting information from their experiences.

Quick facts

Study typeObservational
Enrollment15000 (estimated)
Ages18 Years to 90 Years
SexAll
SponsorUniversity Hospital, Lille Academic / other
Locations31 sites (Amiens and 30 other locations)
Trial IDNCT02526095 on ClinicalTrials.gov

What this trial studies

This observational study focuses on assessing the outcomes of patients with esophageal cancer, gastric cancer, or gastroesophageal junction tumors following surgical intervention. It includes patients who have not received prior treatment or those who have undergone neoadjuvant therapy. The study collects data retrospectively to analyze the effectiveness of surgical procedures in this patient population. Participants will provide informed consent for blood sampling and complete various questionnaires to aid in data collection.

Who should consider this trial

Good fit: Ideal candidates include adults aged 18 and older with a diagnosis of esophageal, gastric, or gastroesophageal junction cancer who have not received prior treatment.

Not a fit: Patients under 18 years old, those unable to consent, or individuals who do not speak French may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the effectiveness of surgical treatments for esophageal cancer, potentially improving patient outcomes.

How similar studies have performed: Other studies evaluating surgical outcomes in esophageal cancer have shown promising results, indicating that this approach is supported by existing research.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria: Patient with

* esophageal cancer, gastric or gastroesophageal junction diagnosed biopsy , regardless of the subtype of cancer, tumor stage or treatment envisaged.
* Naive treatment for this cancer,
* Naive treatment for this cancer , failing that received neoadjuvant treatment ,
* Male or female ≥ 18 years.
* social protection scheme .
* sign a free and informed consent for blood sampling , the different questionnaires and the collection of patient information.

Exclusion Criteria:

Male or female aged ( e) under 18 years.

* Private person of liberty or under supervision (including guardianship ) .
* People who do not speak French.
* Major Nobody unable to consent .
* Patient FREGAT already included in the base.
* Patient Refusal .

Where this trial is running

Amiens and 30 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Esophageal DiseaseEsophagusSurgery
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.